Firms

Virtue

Virtue is a venture capital firm backing healthcare startups at pre-seed and seed stages. It invests in clinical AI, healthcare data infrastructure, biopharma software and new care-delivery models, including neurology practices, autism care and serious mental illness care. Its typical initial investment is USD 500,000 to USD 4 million.

Founded: —
Type: Venture capital

Funds2

Virtue Expansion Fund I LP2026-03-092026-03-09—
Virtue venture capital expansion vehicle formed in 2026. Its March 2026 SEC filing reports USD 25 million sold to one investor against a USD 35 million offering, with USD 10 million remaining. First sale occurred January 26, 2026. Final fund size is undisclosed; the USD 35 million offering is not treated as raised capital. Shares management company and general partner with Virtue V2 LP.
Virtue V2 LP2025-01-152025-01-15$55M
Virtue’s second venture capital fund. Its January 2025 SEC filing reports USD 55.75 million sold to 53 investors, equal to its total offering with nothing remaining. First sale occurred December 31, 2024. The date stored is the SEC filing date, and the amount is the exact reported sold figure rather than the rounded USD 56 million. Managed by Virtue Ventures Management L.L.C.; Sean Doolan is managing member of the general partner.

Team

Operations and support

Emre KaratasInvestor

Sean DoolanInvestor

Investments

$7M2025-01-09	Prudentia Sciences	GV, Virtue, Iaso Ventures
$5M2024	Tuva Health	Y Combinator, Virtue
$—2023-09-27	Evvy	General Catalyst, G9 Ventures, Left Lane Capital, Labcorp, Virtue, Amboy Street Ventures
$—Unknown date	Standard Model Biomedicine	Virtue
$60MUnknown date	Gyde	Lightspeed, MVP Ventures, Optum Ventures, Better, Crystal Venture Partners, Virtue
$60MUnknown date	Gyde	Lightspeed, MVP Ventures, Optum Ventures, Crystal Venture Partners, Better Capital, Virtue

Funds2

Team

Operations and support

Co-investing

Investments